CYT-1010
CYT-1010 is a mu-opioid receptor agonist extracted from patent WO2013173730A2, with EC50s of 13.1 nM and 0.0053 nM on beta-arrestin recruitment and inhibition of cAMP production, respectively[1].
Product Specifications
CAS Number
[213769-33-6]
UNSPSC
12352005
Target
Opioid Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/cyt-1010.html
Purity
99.74
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
OC1=CC=C(C=C1)C[C@@H](C(N[C@H](CCCCNC2=O)C(N[C@@H](CC3=CNC4=C3C=CC=C4)C(N[C@H]2CC5=CC=CC=C5)=O)=O)=O)N
Molecular Formula
C35H40N6O5
Molecular Weight
624.73
References & Citations
[1]Theodore E. Maione, Novel therapeutic uses of mu-opiate receptor peptides. WO2013173730A2.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
ORAI1, CT (ORAI1, CRACM1, TMEM142A, Calcium release-activated calcium channel protein 1, Protein orai-1, Transmembrane protein 142A) (MaxLight 750) discontinued
